Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 20, 2019
CherryCircle announced the appointment of Emma Cartmell to its board of directors.
read more
Chesapeake IRB announced it has acquired Institutional Biosafety Corporation (IBC), a provider of institutional biosafety committee services located in Rockville, Md.
read more
Chesapeake IRB announced it has acquired MaGil IRB, a central IRB located in Rockville, Md.
read more
Thursday, September 22, 2016
Chesapeake IRB, a provider of independent institutional review board services for the life science industry, has hired Randall Hein, an executive with more than 20 years of experience in operations, sales and consulting for life science organizations...
read more
Tuesday, November 07, 2017
Chesapeake IRB and Schulman IRB have combined to create Advarra, the premier provider of IRB, institutional biosafety committee and research compliance services in North America.
read more
Chi-Med and BeiGene have entered into a collaboration agreement to evaluate two of Chi-Med’s drug candidates, surufatinib and fruquintinib, with BeiGene’s anti-PD-1 antibody tislelizumab, for solid tumor cancers.
read more
Monday, February 26, 2018
Recipharm AB announced that Henrik Stenqvist has resigned from his position with the company to pursue other opportunities.
read more
Wednesday, December 28, 2016
Recipharm AB has announced that its Chief Financial Officer (CFO) Björn Westberg has resigned from his position with the company.
read more
Tuesday, September 01, 2020
Chiesi Group has selected JAGGAER to strategically and progressively advance and expand its supplier management program across its 29 affiliates and into indirect and industrial supply categories.
read more
Wednesday, February 27, 2019
Chiesi USA will occupy the top two floors of Regency Woods II, a six-story development by The Spectrum Companies located off U.S. 64 near Symphony Lake in North Carolina.
read more
Chiltern has acquired Integrated Development Associates, a CRO specializing in integrating Japan and Asia into global drug development.
read more
Chiltern is expanding its clinical development services in endocrinology and metabolism and has named Randy L. Anderson, Ph.D., as senior vice president of scientific affairs.
read more
Wednesday, February 01, 2017
Chiltern has announced the opening of its new process and technology center in Bangalore, India. The new office is a direct result of the company’s continued success and fulfills a need to further enhance its global data capabilities.
read more
Chime Biologics, a CDMO, announced that it has established 3-way strategic cooperation with Leads Biolabs and BeiGene to accelerate LBL-007 mAb development and manufacturing for speedy clinical advancement.
read more
Monday, September 25, 2023
Chime Biologics, a biologics CDMO, announced a strategic cooperation with Kings Pharm.
According to the agreement, Chime Biologics will leverage its rich experience in biosimilar projects to provide cell line development, early process development, ...
read more